{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-051196","form_type":"8-K","ticker":"CING","cik":"0001862150","company_name":"Cingulate Inc.","filed_at":"2024-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.151374+00:00","generated_at":"2026-05-28T23:48:33.976104+00:00","sec_items":["1.01","2.03","7.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cingulate raises $5M via 9% promissory note; cash runway into Q4 2025, NDA target mid-2025","bullets":["Net proceeds of $5.0M from $5.48M unsecured note (9% interest, 18-month maturity, $450K OID).","Cash runway extended to Q4 2025; NDA submission for CTx-1301 targeted for mid-2025.","Lender Streeterville Capital; monthly redemption cap $550K from July 2025; default triggers 15%/5% balance increases.","Guarantees from subsidiaries Cingulate Therapeutics LLC and Cingulate Works, Inc."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-051196","json":"https://secwatch.observer/filing/0001493152-24-051196.json","markdown":"https://secwatch.observer/filing/0001493152-24-051196.md","text":"https://secwatch.observer/filing/0001493152-24-051196.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224051196/0001493152-24-051196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224051196/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:48:33.976104+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}